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Abstract
Rapid and accurate diagnosis of foot-and-mouth disease (FMD) and virus serotyping are of
paramount importance for control of this disease in endemic areas where vaccination is
practiced. Ideally this virus characterization should be achieved without the need for virus
amplification in cell culture. Due to the heterogeneity of FMD viruses (FMDVs) in different
parts of the world, region specific diagnostic tests are required. In this study, hydrolysable
probe-based real time reverse transcription quantitative polymerase chain reaction (RT-
qPCR) assays were developed for specific detection and serotyping of the FMDVs currently
circulating in West Eurasia. These assays were evaluated, in parallel with pan-FMDV diag-
nostic assays and earlier serotype-specific assays, using field samples originating from
Pakistan and Afghanistan containing FMD viruses belonging to different sublineages of O-
PanAsia, A-Iran05 and Asia-1 (Group-II and Group-VII (Sindh-08)). In addition, field sam-
ples from Iran and Bulgaria, containing FMDVs belonging to the O-PanAsiaANT-10 subline-
age were also tested. Each of the three primer/probe sets was designed to be specific for
just one of the serotypes O, A and Asia-1 of FMDV and detected the RNA from the target
viruses with cycle threshold (CT) values comparable with those obtained with the serotype-
independent pan-FMDV diagnostic assays. No cross-reactivity was observed in these
assays between the heterotypic viruses circulating in the region. The assays reported here
have higher diagnostic sensitivity (100% each for serotypes O and Asia-1, and 92% [95%
CI = 81.4–100%] for serotype A positive samples) and specificity (100% each for serotypes
O, A and Asia-1 positive samples) for the viruses currently circulating in West Eurasia
compared to the serotyping assays reported earlier. Comparisons of the sequences of
the primers and probes used in these assays and the corresponding regions of the circulat-
ing viruses provided explanations for the poor recognition of some of the viruses by the
earlier assays. These new assays should help in the early detection and typing of serotype
O, A and Asia-1 FMDVs circulating in West Eurasia to enable improved disease control.
PLOS ONE | DOI:10.1371/journal.pone.0135559 August 13, 2015 1 / 16
OPEN ACCESS
Citation: Jamal SM, Belsham GJ (2015)
Development and Characterization of Probe-Based
Real Time Quantitative RT-PCR Assays for Detection
and Serotyping of Foot-And-Mouth Disease Viruses
Circulating in West Eurasia. PLoS ONE 10(8):
e0135559. doi:10.1371/journal.pone.0135559
Editor: Nagendra R Hegde, Ella Foundation, INDIA
Received: April 8, 2015
Accepted: July 23, 2015
Published: August 13, 2015
Copyright: © 2015 Jamal, Belsham. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: The work was funded internally within the
DTU (Technical University of Denmark) National
Veterinary Institute (www.vet.dtu.dk) and in part by
the European Commission for the Control of Foot-
and-mouth disease (EuFMD)(http://www.fao.org/ag/
againfo/commissions/eufmd/commissions/eufmd-
home/en/). The funders had no role in study design,
data collection and analysis, decision to publish, or
preparation of the manuscript.
Introduction
Foot-and-mouth disease (FMD) is an infectious and highly contagious disease of cloven-
hoofed domestic and wild animals, particularly cattle, buffalo, sheep, goats and pigs. The dis-
ease is caused by FMD virus (FMDV), belonging to the genus Aphthovirus within the family
Picornaviridae [1]. FMDV is non-enveloped and has a single-stranded positive polarity RNA
genome of about 8.3 kilobases. The virus exists in seven immunologically distinct serotypes: O,
A, C, SAT (Southern African Territories) 1, SAT 2, SAT 3 and Asia-1. Multiple subtypes can be
identified within each serotype that sometimes fail to induce good cross-protection against
other viruses of the same serotype. The seven serotypes are not distributed uniformly around
the world. Historically, the serotype O, A and C FMDVs have had the widest distribution glob-
ally and have been responsible for outbreaks in Europe, America, Asia and Africa but serotype
C has not been detected anywhere since 2005 [2]. The serotype SAT 1, SAT 2 and SAT 3
viruses are normally confined to sub-Saharan Africa while serotype Asia-1 is restricted to Asia
but occasional incursions of SAT serotypes into the Middle East/North Africa and of serotype
Asia-1 into Europe have occurred [1].
FMD causes heavy economic losses to the livestock industry globally with an estimated
annual cost of USD 6 to21 billion in agricultural damage and prevention expenditure [3] and
has enormous potential impact on food security. The disease is endemic in many countries of
Africa and Asia. In contrast, Europe, North America, Australia, New Zealand and some coun-
tries in Asia (e.g. Japan and South Korea) are normally free of FMD. However, outbreaks can
spread from endemic areas to disease-free countries as occurred in recent years in the United
Kingdom, France and The Netherlands in 2001 [4], Japan and Korea during 2000, 2010 and
2014, and Bulgaria during 2010–2011 [5–8].
Rapid and accurate diagnosis of FMD is of paramount importance for control of the disease.
Various pan-FMDV reverse transcription quantitative polymerase chain reaction (RT-qPCR)
assays for the detection of FMDV have been reported [9–12]. These assays target highly con-
served RNA sequences either within the 5'-untranslated region (UTR) or in the sequences cod-
ing for non-structural proteins and they can efficiently detect each of the seven serotypes from
clinical samples. These diagnostic assays possess high analytical sensitivity and specificity.
Their analytical sensitivity has been shown to be at least equal to that of the current reference
standard method, i.e. virus isolation in cell culture [12–14]. However, these assays do not deter-
mine the serotype of the particular FMDV that is detected. Identification of the serotype of the
causative virus from outbreaks is important for vaccine selection, especially in endemic coun-
tries, for control of the disease. This is normally carried out using antigen detection ELISA but,
as this test only has ca. 70% sensitivity (in clinical samples) [15], it is often necessary to propa-
gate the virus in susceptible cells prior to this assay to establish the serotype and this clearly
extends the duration of the procedure.
The VP1 is a surface exposed capsid protein that plays an important role in the antigenicity
and pathogenicity of FMDV. It contains important immunogenic sites including amino acid
residues within the G-H loop and the C-terminus. The G-H loop also includes an arginine-gly-
cine-aspartic acid (RGD) motif, which is required for attachment of the virus to integrin recep-
tors on the host cell [16,17]. Due to their heterogeneity, the nucleotide sequences encoding
VP1 are extensively used for the determination of genetic relationships between different
strains and for the tracing of the origin and movement of outbreak strains [18–23].
Conventional RT-PCR assays using primers targeting the VP1 coding region for serotyping
of FMDV have been reported [24–26]. However, these assays either have relatively poor sensi-
tivity and specificity, due to the genetic diversity within all FMDV serotypes, or are cumber-
some and unsuitable for routine use [27,28]. Furthermore these assays are not sensitive enough
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to replace antigen detection and serotyping ELISA and virus isolation although they can be
used as supportive tests [29,30]. Ideally, the serotyping should be performed without the need
for virus amplification in cell culture.
Due to the heterogeneity of FMDVs circulating in different parts of the world, region-spe-
cific tests are required. Region-specific antigen detection ELISA and conventional RT-PCR
assays for differentiation of FMDV serotypes, using multiple primers designed from nucleotide
sequences of viruses circulating in that geographical area, have been developed [31]. These
assays demonstrated the potential use of tailored molecular tools for the identification of sero-
type(s), within specific geographical regions, as an alternative to, or support for, the pan-
FMDV RT-qPCR assays. Region-specific RT-qPCR assays have recently been reported for
detection of SAT 2 (Group-VII) FMDVs circulating in East Africa [32] and for the serotyping
of FMDVs circulating in the Middle East [33] and East Africa [34]. This study builds on the
use of such systems as described previously.
Analyses of field samples from Pakistan and Afghanistan using primers and probes
described by Reid and colleagues [33] showed that some viruses were not detected in these
assays although they were positive in the pan-FMDV RT-qPCR assays described previously
[10,12]. This failure in virus detection indicates the need to develop further RT-qPCR assays
for typing of FMDVs (serotypes O, A and Asia-1) that circulate in West Eurasia. The present
study was aimed at the development of such assays and to assess these assays in comparison
with those described earlier [33].
Materials and Methods
Design of serotype-specific primers and TaqMan probes
FMDV VP1 coding region sequences derived from viruses originating within the West Eur-
asian region were obtained from GenBank (www.ncbi.nlm.nih.gov). These sequences were
aligned using MEGA 6 [35] and conserved regions were identified. Serotype-specific primers
and probes for serotypes O, A and Asia-1 FMDVs were designed from the conserved sequences
in the alignments (see Table 1).
Samples
Field samples (epithelial or oral swabs) originating from Pakistan and Afghanistan, containing
FMDVs belonging to the lineages O-PanAsia, A-Iran05, A-Pak09 and Asia-1 (Groups II
and VII), collected under the Italian funded FAO regional project, GTFS/INT/907/ITA (as
described previously [20–22]), were used to evaluate the assays for the FMDV serotypes O, A
Table 1. Sequences of primer and probe sets designed for serotyping of West Eurasian FMDVs using RT-qPCR assays.
Name of Primer/probe Orientation FMDV serotype Sequence (5'– 3')
O-JB-F Forward O GAGACAGCGTTGGAYAACACC
O-JB-R Reverse O TGWGGTGCCGTGTAAGGCAG
O-JB-F-P —- O Fam—AATCCAACGGCTTACCACAAGGCACC—Tamra
A-JB-F Forward A GCCACGACCATCCACGAGCT
A-JB-R Reverse A GTCCTGYGACRACACTTCCAC
A-JB-F-P —- A Fam—CTCGTGCGYATGAAACGTGCYGAGCT—Tamra
As-JB-F Forward Asia-1 TGCCYACYTCXTTYAAYTACGG
As-JB-R Reverse Asia-1 CARAGGYCTRGGGCAGTATGT
As-JB-F-P —- Asia-1 Fam—CGTTTCATGCGRATYAAMAGCTCAGTGAT—Tamra
doi:10.1371/journal.pone.0135559.t001
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and Asia-1. The serotype and subtypes of these samples had been identified using phylogenetic
analyses of the VP1 coding sequences of these viruses. These sequences have been deposited in
GenBank and the accession numbers are listed (see S1 Table and [20–22,36]). In addition, the
serotype of a few samples had been determined using the antigen-ELISA. One sample (2953),
that was positive in the pan-FMDV RT–qPCR assays, had not been serotyped, by sequencing,
due to inadequate yield of product in the RT-PCR. Clinical samples collected from cases of
FMD from Iran (2010) (unpublished results) and Bulgaria (2011) [5] were also included in the
analyses. Details of the all the samples are shown in the S1 Table.
Sample preparation
Epithelial samples. The epithelial samples were homogenized in RLT buffer (Qiagen, Hil-
den, Germany) prior to RNA extraction as described previously [20]. Briefly, the epithelial
samples were processed by mixing with disruption beads and 1 ml of RLT buffer in a homoge-
nizer (FastPrep, FP120 Thermo Electron Corporation) for 30 seconds at a setting of 6.5 m/s.
After centrifugation of the homogenate at 14462 × g for 10 minutes (min), the supernatants
were passed through QIA Shredder Mini Spin Columns (Qiagen). The filtrates were used for
RNA extraction.
Oral swab samples. The oral swab samples, preserved in RLT buffer, were thawed, vor-
texed and then centrifuged at 664 × g for 10 min. The supernatants were used for RNA
extraction.
RNA extraction and cDNA synthesis
Total RNA was extracted from the samples either using manual (QIAamp RNA Blood Mini
Kit) or robotic (MagNA Pure) protocols as described elsewhere [23]. In each case, the RNA
was eluted in 50 μl of water.
The cDNA was synthesised by adding 7 μl of random hexamer primers (50 ng/μl) to 20 μl
of template RNA and 8 μl water. The samples were heated to 65°C for 10 min, cooled on ice for
2 min and then transferred into tubes containing Ready-to-Go beads (GE Healthcare Life Sci-
ences), vortexed and incubated at 40°C for 60 min followed by incubation at 90°C for 5 min to
heat inactivate the reverse transcriptase. Water was added to the cDNA to give a volume of
200 μl to provide sufficient test material for each of the assays.
Pan-FMDV and serotype-specific RT-qPCR assays
The cDNA was used in RT-qPCR assays using the serotype-specific primers/probes sets
designed in this study and run in parallel with the primers/probe set described by Reid and col-
leagues [33] and the pan-FMDV primers/probe sets targeting the 3D coding region [10] and
the 50-UTR [12]. The reactions were performed in a MX4000 thermal cycler (Stratagene, The
Netherlands) using 50 cycles of amplification with the following programme: 50°C for 2 min
for UNG digestion, 1 cycle; denaturation at 95°C for 10 min, 1 cycle; 95°C for 15 sec, 60°C (or
55°C for Asia-1 assay) 1 min, 50 cycles. The CT values obtained with pan-FMDV assays (3D
and 5'-UTR) and the serotype-specific assays were compared. The primers/probe sets of the
serotype-specific assays were aligned (using MEGA6 software) with the VP1 coding region
nucleotide sequences of the samples that were not efficiently amplified in the assays or showed
a clear (>4) difference in CT values between the different assays.
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Results
Diagnostic sensitivity and specificity of serotype-specific RT-qPCR
assays
RNA samples derived from known cases of FMD were assayed using the well-established diag-
nostic RT-qPCR assays [10,12]. These assays included the pan-FMDV assays, targeting part of
the 3D coding region and the 5'-UTR within the FMDV genome, plus the serotype-specific
assays described previously [33] that target the VP1 coding regions of FMDV serotypes circu-
lating in the Middle East. In addition, the same samples were assayed using the multiple prim-
ers/probe sets designed in this study to recognize the coding sequences for the VP1 proteins of
FMDV serotypes O, A and Asia-1 currently circulating in West Eurasia. The data generated
are summarized in Table 2. The pan-FMDV assays confirmed the presence of FMDV RNA in
all the 59 samples tested.
Use of the “first generation” serotype specific assays. The “first generation” serotype O-
specific RT-qPCR assay described previously by Reid and colleagues [33] were able to identify
FMDV serotype O in 22 out of 24 samples that were known to be positive for serotype O
FMDV. These samples contained various different virus strains within O-PanAsia i.e. O-PanA-
sia-IIANT-10, O-PanAsia-IIFAR-09, O-PanAsia-IIPUN-10, O-PanAsia-IIBAL-09 and O-PanAsia-III
(Fig 1). Two samples could not be detected by these serotype O-specific assays; these belonged
to the O-PanAsia-IIANT-10 sublineage (sample No. Nzm21) and O-PanAsia-III (sample No.
1343) lineage. Indeed, the latter sample was mis-classified as belonging to serotype A using this
assay. However, the assay was able to identify one sample (B-17), obtained from serotype O
FMDV outbreaks in Bulgaria in 2011, as serotype O that had been identified as positive in the
pan-FMDV RT-qPCR but its serotype was unknown. Using this collection of samples, the
diagnostic sensitivity of the “first generation” serotype O specific assay was found to be 91.7%
[95% CI = 80.6–100%] and the specificity was 97.1% [95% CI = 91.6–100%].
The Reid et al. [33] serotype A-specific assay correctly detected and identified serotype A
FMDV in 21 out of 25 serotype A FMDV positive samples. Among the four samples which were
not detected, two belong to the A-Iran05 lineage while two others belong to a different lineage,
designated as the A-Pak09 lineage [22] (Fig 2). The two undetected FMDVs belonging to the
A-Iran05 lineage were members of the A-Iran05AFG-07 and A-Iran05KUN-09 sublineages (note
this sub-lineage has also been termed A-Iran05ESF-10 by theWRL-FMD). The diagnostic sensitiv-
ity of this assay was calculated to be 84% [95% CI = 69.6–98.4%] and the specificity was 97.1%
[95% CI = 91.6–100%]. The “first generation” serotype Asia-1 specific assay successfully detected
all the 10 serotype Asia-1 positive samples belonging to two different Groups, i.e. Group II and
Group VII/Sindh-08 (Fig 3), thus showing 100% diagnostic sensitivity and specificity.
Table 2. Summary of the RT-qPCR results using serotype O-, A- and Asia-1-specific and pan-FMDV 5'-UTR and 3D assays.
Serotype 5'-UTR
assay
3D
assay
O (Reid et al.
[33] assay)
O (“2nd
generation”
assay)
A (Reid et al.
[33] assay)
A (“2nd
generation”
assay)
Asia-1 (Reid
et al. [33]
assay)
Asia-1 (“2nd
generation” assay)
O 24*/24 24/24 23**/24 24/24 1/24 0/24 0/24 0/24
A 25/25 25/25 0/25 0/25 21/25*** 23/25*** 1/25*** 1/25**
Asia-1 10/10 10/10 0/10 0/10 0/10*** 1/10*** 10/10 10/10
* two samples had high Ct values (38.9 and 37.9)
** two samples had high Ct values (38.1 and 38.9)
*** includes sample positive for both serotypes A and Asia-1
doi:10.1371/journal.pone.0135559.t002
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Use of “second generation” serotype-specific assays. The “second generation” serotype
O-specific assay described here successfully detected and identified all the 24 serotype O
FMDVs tested. As with the earlier serotype O-specific assay [24], the new assay was able to
assign serotype identity to one sample (B-17) that had been identified as positive in the pan-
FMDV RT-qPCR but whose serotype was unknown. Both the diagnostic sensitivity and speci-
ficity of this assay was found to be 100%. In addition, of the 25 serotype A FMDV positive
samples, the “second generation” serotype A-specific assay detected 23 of them but could not
detect two. These two samples belonged to the A-Pak09 lineage (Fig 2) and were not detected
by the Reid et al. [33] assays either (see above). The diagnostic sensitivity and specificity of this
assay was found to be 92% [95% CI = 81.4–100%] and 100%, respectively. The new serotype
Asia-1-specific assay correctly classified all the 10 serotype Asia-1 FMDVs as positive for this
serotype with no cross reactivity with other serotypes, showing 100% diagnostic sensitivity and
specificity.
Fig 1. Diagnostic sensitivity and specificity of FMDV serotype O specific RT-qPCR assays. The CT values obtained in the different RT-qPCR assays
for the indicated serotype O virus samples are shown. The genetic relationships between the various strains fromWest Eurasia, based on VP1 coding
sequences, are also indicated.
doi:10.1371/journal.pone.0135559.g001
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As indicated above, one serotype O positive sample (1343) tested positive for serotype A
in the Reid et al. [33] serotype A specific assay but negative with the serotype O-specific set.
This sample was, however, identified as positive only for serotype O using the “second genera-
tion” serotype-specific assays (Fig 1), consistent with the sequence determination. In principle,
it is possible, although unlikely, that this sample contained a mixture of serotype O and A
viruses and that the new serotype A-specific assay failed to detect the presence of the serotype
A virus while the Reid et al. [33] serotype O-specific assay failed to detect the serotype O
FMDV. In summary, no apparent cross-reactivity was observed when the “second generation”
serotype-specific assays were tested on samples containing each of the serotype O, A and Asia-
1 FMDVs. Sample No. 8, which contained both serotypes A and Asia-1 [21,22], tested positive
for both serotypes within the “second generation” serotype-specific assay as expected. This
sample tested positive for serotype Asia-1 FMDV with the Reid et al. [33] serotype-specific
assay but not for serotype A. Both the “first” and “second generation” serotype-specific assays
were successful in assigning the serotype identity to sample No. 2953 as serotype Asia-1, that
Fig 2. Diagnostic sensitivity and specificity of FMDV serotype A-specific RT-qPCR assays. The CT values obtained in the different RT-qPCR assays
for the indicated serotype A virus samples are shown. The genetic relationships between the various strains fromWest Eurasia, based on VP1 coding
sequences, are also indicated. Note, sample 8 is marked with an * to indicate this sample contained two different serotypes of FMDV.
doi:10.1371/journal.pone.0135559.g002
RT-qPCR Assays for Detection and Serotyping of FMDVs
PLOSONE | DOI:10.1371/journal.pone.0135559 August 13, 2015 7 / 16
was also positive in both the pan-FMDV 3D and 5'-UTR assays but could not be sequenced
(and hence serotyped) due to the low yield of the conventional RT-PCR product.
Comparison of cycle threshold (CT) values obtained in the different RT-
qPCR assays
A comparison between the cycle threshold (CT) values for the pan-FMDV assays, the Reid
et al. [33] serotype-specific assays and the “second generation” serotype-specific assay is shown
in Fig 4. Similar CT values were obtained for the samples positive in the pan-FMDV assays and
the “second generation” assays. In contrast, CT values obtained with pan-FMDV 3D assay and
the Reid et al. [33] assays show some differences particularly for the serotype O and A FMDVs
that were tested. Lower CT values were obtained in the “second generation” assay for 8 samples
belonging to serotype O and for 4 serotype A FMDVs compared to the Reid et al. [33] assays
(Figs 1 and 4), indicating that the new assays are more sensitive. Although no significant differ-
ences were noted in CT values obtained between the two serotype-specific assays specific for
the serotype Asia-1 FMDVs, clear differences can be noted in the slope of the amplification
curves for the two assays (please see below for more detail).
Nucleotide substitutions at primer/probe binding sites
The FMDV RNA samples which were not detected in either of the two serotype-specific assays
or that showed a clear (>4) difference in the CT values between these assays were investigated
further. The primer/probe binding sites within the virus genomes were compared to the respec-
tive primer and probe sequences to identify nucleotide substitutions at these sites; these are
shown in Fig 5. One nucleotide mismatch to the forward primer and four nucleotide mis-
matches to the reverse primer were noted in the corresponding binding sites within the VP1
Fig 3. Diagnostic sensitivity and specificity of FMDV serotype Asia-1-specific RT-qPCR assay. The CT values obtained in the different RT-qPCR
assays for the indicated serotype Asia-1 virus samples are shown. The genetic relationships between the various strains fromWest Eurasia, based on VP1
coding sequences, are also indicated. Note, sample 8 is marked with an * to indicate this sample contained two different serotypes of FMDV.
doi:10.1371/journal.pone.0135559.g003
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coding region of the two samples (samples No. 1364 and 1809) which were not amplified in
either the Reid et al. [33] (Fig 5A) or the “second generation” serotype A-specific assay (Fig
5B). As indicated above, these samples contained FMDVs that belong to the A-Pak09 cluster.
Sample No. 1495, which was not detected in the Reid et al. [33] serotype A-specific assay, has
two nucleotide mismatches in the probe binding site (Fig 5A). Similarly, the Reid et al. [33]
serotype A-specific assay failed to identify serotype A within sample No. 8 (which actually con-
tained both serotype A and Asia-1). Comparison of the sequences within the primers and
probe binding sites of this sample revealed three nucleotide mismatches in the reverse primer
of the first generation serotype A-specific assay (Fig 5A). Four serotype A positive samples,
that showed clear difference in CT values between the two serotype-specific assays, have three
nucleotide mismatches in the reverse primer binding site in the Reid et al. [33] serotype A-spe-
cific assay (Fig 5B), which may explain the higher CT values obtained.
Of the two serotype O positive samples that the Reid et al. [33] serotype O-specific assay did
not detect, one (1343, belonging to the O-PanAsia-III lineage) had one nucleotide mismatch in
the forward primer binding site, two mismatches in the probe binding site and three
Fig 4. Comparison of cycle threshold (CT) values obtained in the different RT-qPCR assays.CT values obtained with the pan-FMDV 3D assay, the
Reid et al. [33] assays and “second generation” serotype-specific assays described here for serotypes A, O and Asia-1 viruses are shown.
doi:10.1371/journal.pone.0135559.g004
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substitutions in the reverse primer binding site (Fig 5C). These mismatches may have reduced
the efficiency of detection and it is noteworthy that the level of FMDV RNA in this sample was
low as well (note the high CT values obtained in the pan-FMDV assays). Two mismatches in
the probe binding site and three mismatches in the reverse primer binding site were noted in
the second FMDV (Nzm21, belonging to O-PanAsia-IIANT-10 sublineage) which was not
amplified in the Reid et al. [33] serotype O-specific assay. Among the three mismatches in the
reverse primer binding site, one substitution occurred in the second nucleotide from the 3´ end
(Fig 5C) which may explain this failure in detection.
Comparison of amplification curves of the serotype-specific RT-qPCR
assays
A comparison of the amplification curves of selected samples between the Reid et al. [33] assays
and the “second generation” serotype-specific assays individually for serotypes O, A and Asia-
1 FMDVs is shown in Fig 6. Clear differences can be noted in the slope of amplification curves
of the new (2nd generation) and the Reid et al. [33] serotype O-specific assays (see Fig 6(A)).
The amplification curves seen in the serotype A-specific assays were also more homogeneous
in the new assay compared to the Reid et al. [33] serotype A-specific assay (see Fig 6(B)). Simi-
larly, the amplification curves for serotype Asia-1 FMDVs were more consistent in shape in the
new serotype Asia-1 specific assay and in many cases yielded higher fluorescence (dR) values
compared to that of the Reid et al. [33] assay (Fig 6(C)).
Discussion
Various techniques are in use for diagnosis of FMD including ELISA, virus isolation, conven-
tional and real time RT-qPCR assays [1]. In order to control FMD outbreaks, an early and
accurate identification of the causative FMDV is very important. In countries using a “stamp-
ing out” policy, simple detection of FMDV can be sufficient. Virus detection is usually carried
out using pan-FMDV FMDV RT-qPCR assays that have been extensively evaluated for routine
use [10–12,14]. Simple detection of FMDV using these assays is, however, not sufficient in
countries where prophylactic vaccination is used to contain the disease as serotype identifica-
tion is crucial to allow selection of the most appropriate vaccine, at least at the serotype level, as
there is no cross-protection. Ideally the vaccine should be well matched to the outbreak virus
but often there are practical limitations about this, e.g. in terms of vaccine availability, and vac-
cine matching studies or sequence determination can take some time.
Identification of conserved sequences as targets for primers and probes to specifically recog-
nise all viruses within a particular serotype but without cross reactivity towards viruses of other
serotypes is challenging. This is due to the high heterogeneity within the region of the FMDV
genome (encoding the capsid proteins) that determines serotype and the lack of conserved
sequences within all strains in individual serotypes worldwide. In order to overcome this issue,
efforts have been made to detect viruses belonging to specific lineages within particular sero-
type(s) circulating in distinct geographical regions rather than across all strains globally [32–
Fig 5. Comparison between nucleotide sequences of selected FMDV samples and the primers and probes. Panel (A) Sequences of serotype A FMDV
samples indicating mismatches with primers and probe of the Reid et al. [33] serotype A-specific assay. Samples numbered 1495, 1364 and 2809 were not
detected in the serotype A-specific assays described by Reid and colleagues [33]. Panel (B) Sequences of serotype A FMDVs indicating mismatches with
primers and probe of the new serotype A-specific assay. Samples numbered 1364 and 2809 were not detected in the new assay. Panel (C) Nucleotide
sequences of serotype O FMDV samples indicating mismatches with primer and probe sequences of the Reid et al. [33] serotype O-specific assay. The
samples 1343 and Nzm21 were not detected in this assay.
doi:10.1371/journal.pone.0135559.g005
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Fig 6. Comparison of amplification curves of the serotype-specific RT-qPCR assays. (A) Amplification
curves for the six selected serotype O samples obtained with the 1st generation assay [33] (+ symbols) and
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34]. This study builds on the use of this approach to develop serotype-specific RT-qPCR assays
for detection and serotyping of FMDVs circulating in West Eurasia.
In the present study, primers and probe sets specific for serotypes O, A and Asia-1 FMDV
were designed by individually aligning the VP1 coding sequences of serotypes O, A and Asia-1
FMDV circulating in West Eurasia. Comparison of the VP1 coding nucleotide sequences
reveals a tendency for similar viruses to circulate in the same geographical area and analyses of
these sequences have distributed FMDVs into seven different regional pools [37,38]. The
primer and probe sets designed in this study effectively and specifically detected genomes
belonging to a variety of different FMDV sublineages of O-PanAsia (see Fig 1), A-Iran05 (see
Fig 2) and Asia-1 strains (see Fig 3) as intended. Two samples of serotype A FMDV that were
not detected belong to a distinct lineage, designated as A-Pak09 [22]. The serotype-specific
assays described by Reid and colleagues [33] also failed to amplify these two samples and addi-
tionally failed to amplify some other FMDV positive samples either belonging to the A-Iran05
or the O-PanAsia lineages. The pan-FMDV assays do recognize these strains so it is apparent
that FMDV is present. It should be possible to design assays specifically to detect this lineage if
required. There is a continued need to adapt such assays to strains circulating within a region
but clearly the assays described here recognize most of the viruses that have circulated recently
within this region.
The new assays described here did not show any cross-reactivity with heterotypic serotypes
of FMDV. However, some apparent cross-reactivity was noted in the assays described by Reid
et al. [33] as one sample, identified as positive for serotype O FMDV also tested positive for
serotype A. The clear detection of both serotype A and Asia-1 FMDV in one sample (sample 8)
that indeed contained viruses of both serotypes (see [21,22]) reveals the utility and advantages
of the RT-qPCR assays in identifying mixed infections over ELISA-based assays in which some
cross-reactivity frequently occurs [1].
Cycle threshold (CT) values are not only used to determine the presence of FMDV RNA but
they are also used to quantify the level of viral RNA in a sample. The CT values obtained with
the assays reported here were consistent with that of the pan-FMDV 3D or 5'-UTR assays.
However, differences in CT values were observed between the Reid et al. [33] assays and the
new assays reported here; in some cases, lower CT values were recorded with the new assays
reported here compared to the Reid et al. [33] assays indicative of higher sensitivity.
In the TaqMan RT-qPCR assays, the amount of amplified DNA is measured after each cycle
of amplification via dyes that generate fluorescent signals, the magnitude of which is propor-
tional to the amount of the amplicon generated. The amplification curves, generated by plot-
ting the fluorescence against the number of cycles, represent the accumulation of product over
the duration of the reaction. Initially, the fluorescence signals increase exponentially with the
number of thermal cycles. In general, the magnitude of the fluorescence signal was higher in
the new assays for serotypes O, A and Asia-1 compared to that obtained in the Reid et al. [33]
assays and the amplification curves were more consistent (Fig 6). It is apparent that a small
number of nucleotide mismatches between the primers and probes can have a significant effect
on the ability of the assays to detect the virus (see Fig 5); analogous observations have been
reported previously [13].
the 2nd generation serotype O-specific assay described here (round symbols). (B) Amplification curves for the
six selected serotype A samples obtained with the 1st generation assay [33] (+ symbols) and the 2nd
generation serotype A-specific assay described here (round symbols). (C) Amplification curves for the six
selected serotype Asia-1 samples obtained with the 1st generation assay [33] (+ symbols) and the 2nd
generation serotype Asia-1-specific assay described here (round symbols).
doi:10.1371/journal.pone.0135559.g006
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Although the new serotype A-specific assays also failed to detect two samples positive for
serotype A FMDVs (these do not belong to the A Iran05 lineage), the new serotype specific
assays reported here have clear advantages over the Reid et al. [33] assays for samples collected
within West Eurasia (e.g. see Fig 6) and thus may help in the early detection and typing of
FMDV serotypes O, A and Asia-1 circulating there. Due to continuous changes in the FMDV
RNA sequences, monitoring of the sequences, within circulating strains, at the primer and
probe binding sites is required to ensure that the diagnostic sensitivity and specificity of these
assays is maintained.
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